1.Synchronous Development of Schwannoma in the Rectus Abdominis and Lipoma in the Chest: A Case Report.
Ju Oh KIM ; Ki Yong AN ; Hwang Se BONG ; Kyu Jung LEE
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):109-112
We experienced a case of 63 years old male patient who had synchronous rectus abdominis intramuscular schwannoma and chest wall lipoma. Schwannoma is rare benign tumor which derived from nerve sheath and mainly peripheral nerve of flexor part. The authors report rare synchronous schwannoma and lipoma development.
Humans
;
Lipoma*
;
Male
;
Neurilemmoma*
;
Peripheral Nerves
;
Rectus Abdominis*
;
Thoracic Wall
;
Thorax*
2.Bizarre Parosteal Osteochondromatous Proliferation in the First Metatarsal Bone: A Case Report.
Woo Sung KIM ; Yu Hun JUNG ; Sang Hun OH ; Eun Mee HAN
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):104-108
Bizarre parosteal osteochondromatous proliferation (Nora's lesion) is a rare benign tumor and known to be primarily occur in the small tubular bone of the hands and feet. However, it is very unusual to be reported that it occurs in metatarsal bone in Korea. Thus, we report this tumor of metatarsal bone including the literature review because we have experienced this example.
Foot
;
Hand
;
Korea
;
Metatarsal Bones*
3.Osteosarcoma with Adenocarcinoma of Lung in Li-Fraumeni Syndrome: A Case Report.
Chang Seon OH ; Jin Ho LEE ; Sung Taek JUNG ; Bo Ram NA
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):99-103
Li-Fraumeni syndrome (LFS) is an autosomal dominant hereditary disorder characterised by a variety of different tumor types in children and young adults. That contains with a germline mutation in the tumor suppressor gene Tumor Protein p53 (TP53). That is extremely rare. Furthermore, this is sometimes overlooked. Here, we report a case of LFS which was confirmed by mutational analysis of the p53 gene. Also, literature review is intended to improve understanding of this disease entity.
Adenocarcinoma*
;
Child
;
Genes, p53
;
Genes, Tumor Suppressor
;
Germ-Line Mutation
;
Humans
;
Li-Fraumeni Syndrome*
;
Lung*
;
Osteosarcoma*
;
Young Adult
4.Osteoid Osteoma in Wrist: A Case Report.
Chae Chil LEE ; Sang Woo KIM ; Seung Hyun JUNG
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):94-98
Osteoid osteoma can occur in all parts of the skeletal system. More than half occur in lower extremity and rare in wrist.Clinically pain is almost the only symptom worse at night and which is characterized by a rapid improvement by NSAID. We report the cases of osteoid osteoma which shows the characteristic symptoms and got a good results with appropriate imaging work up and surgical treatment.
Lower Extremity
;
Osteoma, Osteoid*
;
Wrist*
5.Clear Cell Chondrosarcoma of the Tibia Diaphysis: A Case Report.
Chang Min KANG ; Chung Soo HAN ; Gwang Young JUNG ; Ho Yeon JEONG ; Young Jun KIM
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):89-93
Clear cell chondrosarcoma is a very rare malignant bone tumor that shows a strong predilection for the epiphysis or metaphysis of long bones. Many studies have reported that the proximal end of the femur is the most commonly affected site, followed by the proximal end of the humerus. Histopathologically, tumor cells of this type have centrally located round nucleoli with clear cytoplasm and a distinct cytoplasmic membrane. Generally, clear cell chondrosarcomas is not confused with conventional chondrosarcomas. However, when it involves the diaphysis in long bones, diagnosis can be hindered, as only three reports of this exist in the literature. We report herein an unusual case of clear cell chondrosarcoma of the tibial diaphysis in a 42-year-old male.
Adult
;
Cell Membrane
;
Chondrosarcoma*
;
Cytoplasm
;
Diagnosis
;
Diaphyses*
;
Epiphyses
;
Femur
;
Humans
;
Humerus
;
Male
;
Tibia*
6.A Tenosynovial Giant Cell Tumor Arising from Posterior Cruciate Ligament of Knee Joint: A Case Report.
Hong Kyun KIM ; Chang Hyun CHOI ; Kook Jin CHUNG ; Young Min LEE ; Mi Kyung SHIN ; Ji Hyo HWANG
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):85-88
Localized forms of giant cell tumor are known to arise commonly in the synovial membrane of the finger joints. Multinucleated giant cells are its characteristic pathology finding, giant cell tumor shows a low rate of recurrence after complete excision. When occurring at the knee joints, giant cell tumor manifests a wide form of symptoms, from no symptom at all, to intermittent locking. Complete excision is possible by arthroscopy, but if done incompletely, it is reported to recur in 45% of cases. We present here a case of giant cell tumor that has arisen from the anterior portion of the posterior cruciate ligament, excised by arthroscopy and followed by pathologic confirmation.
Arthroscopy
;
Finger Joint
;
Giant Cell Tumors*
;
Giant Cells
;
Knee Joint*
;
Pathology
;
Posterior Cruciate Ligament*
;
Recurrence
;
Synovial Membrane
7.Inclusion Body Fibromatosis of Finger in a 5-year Old Girl: A Case Report.
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):80-84
Inclusion body fibromatosis is a rare benign soft tissue neoplasm typically involving fingers and toes of children in mostly less than one year old. Histologic findings include spindle-shaped fibroblasts surrounded by dense stroma and small perinuclear eosinophilic inclusions in the cytoplasm. Although the tumor typically undergoes spontaneous regression, surgery is considered when functional impairment or deformity develops with the lesion. Unfortunately, recurrence rate was reported to be as high as 60% following tumor excision. Authors would like to present our case where the tumor occurred in relatively older child and kissing lesion was found a few months after the surgery.
Child
;
Congenital Abnormalities
;
Cytoplasm
;
Eosinophils
;
Female
;
Fibroblasts
;
Fibroma*
;
Fingers*
;
Humans
;
Inclusion Bodies*
;
Recurrence
;
Soft Tissue Neoplasms
;
Toes
8.The Result of Bone Grafting for Fibrous Dysplasia.
Won Ju JEONG ; Tae Seong KIM ; Hwan Seong CHO ; Jong Pil YOON ; Il Hyung PARK
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):74-79
PURPOSE: Fibrous dysplasia is related to the mutation of gene encoding the alpha-subunit of a signal-transducing G-protein and has variable clinical course. Operation can be performed to prevent functional disorder or structural deformity. After curettage, autologous bone graft were used to fill the defects after curettage. The aim of this study is to compare the result of autogenous cancellous bone grafting and allogenic bone grafting for fibrous dysplasia. MATERIALS AND METHODS: Among the patients who visit our hospital during the period of April, 1997 to October, 2013, we selected 34 patients who diagnosed fibrous dysplasia and visited our clinic over 1 year. There were 13 males and 21 females. Average age was 26.4 (range 2 to 57) years old. Autogenous bone graft (group I) in 5 cases, Non-autogenous bone graft (group II) in 30 cases. Iliac bone is used in all cases of autogenous bone graft. There were no significant difference in age, follow-up period, preoperational laboratory finding between two groups. Radiographic image was done to evaluate the recurrence of fibrous dysplasia or secondary degeneration. RESULTS: There were four cases in recurrence (group I: 1 case, group II: 3 cases, p=0.554). In all recurrent cases, reoperations were done using curettage and autogenous iliac bone graft. There was no re-recurrence after reoperation. One case of secondary aneurysmal bone cyst was confirmed (group II) and 1 cases of pathologic fractures had developed (group I: 0 case, group II: 1 cases, p=0.559). No malignant change occurred. CONCLUSION: There were no significant difference between autogenous bone graft group and non-autogenous bone graft group. Our result suggested that autogenous bone graft seems to be good method to treat fibrous dysplasia, in the case of small volume of tumor lesion or non-weight bearing portion.
Aneurysm
;
Bone Cysts
;
Bone Transplantation*
;
Congenital Abnormalities
;
Curettage
;
Female
;
Follow-Up Studies
;
Fractures, Spontaneous
;
GTP-Binding Proteins
;
Humans
;
Male
;
Recurrence
;
Reoperation
;
Transplants
9.Evaluation of Neoadjuvant Chemotherapy Effect in Osteosarcoma.
Min Wook JOO ; Yong Koo KANG ; Ie Ryung YOO ; Woo Hee CHOI ; Yang Guk CHUNG ; Dong Hyun KIM ; Jin Woo KANG
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):66-73
PURPOSE: Various diagnostic imaging modalities have been used to evaluate the effect of neoadjuvant chemotherapy for osteosarcoma early and noninvasively. We evaluated the effectiveness of imaging studies of plain radiographs and positron-emission tomography/computed tomography (PET/CT) in predicting neoadjuvant chemotherapy effect for osteosarcoma and tried to establish a general principle in interpretation of PET/CT parameters. MATERIALS AND METHODS: Eighteen patients who underwent two cycles of neoadjuvant chemotherapy and surgical excision for osteosarcoma were enrolled. There were 13 males and 5 females, with a median age of 19 (11-63) years. Fifteen patients of 18 had the American Joint Committe on Cancer (AJCC) stage IIB. They had plain radiographs and PET/CT before and after neoadjuvant chemotherapy. The resected tumor specimens were pathologically examined to determine histological response grade using a conventional mapping method. Statistical analysis was performed to evaluate the correlation between histopathological necrosis rate, and radiographic finding category, post-chemotherapy maximum standardized uptake value (SUVmax), average standardized uptake value and metabolic tumor volume (MTV) as well as reduction rates of them. RESULTS: Eight patients were good responders to neoadjuvant chemotherapy based on histological evaluation. Median SUVmax reduction rate was 73 (23-77) % in good responders and 42 (-32-76) % in poor responders. Median MTV reduction rate was 93.5 (62-99) % in good responders and 46 (-81-100) % in poor responders. While radiographic finding category was not different according to histological response (p=1.0), SUVmax reduction rate was significantly different (p=0.041). Difference in MTV reduction rates approached statistical significance as well (p=0.071). CONCLUSION: While radiographic finding category was not reliable to assess neoadjuvant chemotherapy effect for osteosarcoma, reduction rate of SUVmax was a useful indicator in this study. As parameters of PET/CT can be influenced by various factors of settings, different centers have to make an effort to establish their own standard of judgement with reference of previous studies.
Diagnostic Imaging
;
Drug Therapy*
;
Female
;
Humans
;
Joints
;
Male
;
Necrosis
;
Neoadjuvant Therapy
;
Osteosarcoma*
;
Positron-Emission Tomography
;
Positron-Emission Tomography and Computed Tomography
;
Tumor Burden
10.Diagnostic Value of MRI in Schwannoma.
Jeung Il KIM ; Um Ji KIM ; Tae Yong MOON ; In Sook LEE ; You Seon SONG ; Kyung Un CHOI
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):60-65
PURPOSE: To diagnose soft tissue tumor, such as lipoma and Schwannoma, magnetic resonance imaging (MRI) is sufficient in most cases. However, various characteristics are found in MRI images of Schwannoma, thus other type of tumors are often misdiagnosed as Schwannoma with MRI images. In this study, we evaluate the diagnostic value of specific MRI findings of Schwannoma. MATERIALS AND METHODS: From January 2002 to May 2013, 104 patients who are suspected as Schwannoma rith MRI images are included in data, and the final diagnosis is confirmed with biopsy. Patients are divided into group 1 and group 2 who are confirmed as Schwannoma and other disease with biopsy, respectively. RESULTS: 92 patients were diagnosed as Schwannoma (group 1) and 12 patients were diagnosed as other disease (group 2). We investigate the diagnostic value of specific MRI findings of Schwannoma. 41 patients of group 1 (45%) and 0 patients of group 2 (0%) showed target sign, 47 patients of group 1 (51%) and 2 patients of group 2 (17%) showed fascicular sign, 44 patients of group 1 (48%) and 5 patients of group 2 (42%) showed fat split sign, 28 patients of group 1 (30%) and 1 patients of group 2(9%) showed nerve entering and exiting sign, and 8 patients of group 1 (9%) and 6 patients of group 2 (50%) showed none of four specific findings on their MRI images. 52 patients of group 1 (57%) and 5 patients of group 2 (42%) have tumors on the pathway of nerve. Target sign could be considered as the best diagnostic value of the sign we investigate (p<0.05). CONCLUSION: Although specific MRI findings have powerful diagnostic value, patients are often misdiagnosed as Schwannoma with MRI findings. Therefore, if patients who are suspected as Schwannoma based on MRI findings have no target sign on their MRI images, we should consider the possibility of other disease.
Biopsy
;
Diagnosis
;
Humans
;
Lipoma
;
Magnetic Resonance Imaging*
;
Neurilemmoma*

Result Analysis
Print
Save
E-mail